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SUMMARY. It is well established that fetal pulmonary sequestration complicated by non-immune hydrops fetalis is
associated with a high risk of mortality; however, antenatal management remains controversial in these rare cases. The
main therapeutic strategies aim to drain the effusions in utero, although there is still debate as to the most adequate
drainage route. The two main options are thoracoamniotic shunting and serial thoracocentheses. Others include medical
inotropic therapy, alcohol ablation of the vascular pedicle, open fetal surgery and ablation of the feeding vessel with laser
surgery. We report the case of a twin pregnancy in which one of the fetuses was affected by an extralobar pulmonary
sequestration with large hydrothorax that was successfully treated with serial thoracocentheses.
Stru~ni ~lanak
Klju~ne rije~i: pulmonalna sekvestracija, fetalna terapija, blizanci
SA@ETAK. Poznato je da je fetalna plu}na sekvestracija komplicirana neimunolo{kim hidropsom povezana s visokim
rizikom mortaliteta; prenatalni postupak je u tim rijetkim slu~ajevima proturje~an. Glavna terapijska strategija je u
in utero drena`i izljeva, a jo{ se raspravlja o najprikladnijem na~inu drena`e. Dvije su glavne mogu}nosti: torako-am-
nionska prijemosnica i ponovljene serijske torakocenteze. Druge mogu}nosti su medikamentozna inotropna terapija,
ablacija vaskularne peteljke alkoholom, otvorena fetalna kirurgija i laserska ablacija opskrbne krvne `ile. Prikazana je
blizana~ka trudno}a s ekstralobarnom plu}nom sekvestracijom i jakim hidrotoraksom u jednoga fetusa, uspje{no lije~ena
serijskom torakocentezom. U 35. tjednu trudno}e je po~eo spontani porod, dovr{en carskim rezom. Nezahva}eni fetus je
bio te`ine 1800 grama, a zahva}eni 2700 grama. Zahva}eno novoro|en~e je trebalo ventilatornu potporu, a s 26 dana
`ivota u~injen je kirur{ki zahvat. Nakon jedne godine `ivota oba su novoro|en~eta zdrava.
Introduction
Bronchopulmonary sequestration is a mass of abnor-
mal, non-functioning pulmonary tissue that does not
communicate with the normal tracheobronchial tree and
whose blood supply is from the systemic circulation.
Lesions receive systemic arterial blood supply from an
aberrant aortic branch.1 Venous drainage is typically
through the azygous system or the inferior vena cava;
however, in 25% of cases the venous drainage is through
the pulmonary veins. Anatomically, there are two sub-
types of pulmonary sequestration: the intralobar mass
located within the substance of a lung lobe, and an
extralobar one, which has its own pleural investment.2
On prenatal ultrasonography, an extralobar pulmonary
sequestration appears as a well-defined, echodense, ho-
mogeneous mass. The detection by colour flow Doppler
ultrasonography of a systemic artery arising from the
aorta to the fetal lung lesion is a pathognomonic feature
of this pathology.3,4 Rarely, sonographic findings may
also include pleural effusion, mediastinal compression,
hydrops and polyhydramnios.5
In cases with hydrops the prognosis is poor and asso-
ciated with a high rate of perinatal mortality and severe
respiratory insufficiency in the newborn.6 The prognosis
depends on the size of the lung mass and the secondary
pathophysiological effects: mediastinal shift, polyhy-
dramnios, hypoplasia and cardiovascular compromise
leading to fetal hydrops and death. However, the man-
agement of fetal hydrothorax is controversial given the
fact that in utero spontaneous resolution has been de-
scribed.7 Draining these effusions in utero, and thereby
decompressing the fetal thorax, can improve survival,
although the best means to effect adequate drainage re-
mains controversial.8 Some authors advocate serial tho-
racocentheses, whereas others recommend thoracoam-
niotic shunting.9
We report the case of a twin pregnancy in which one of
the fetuses was affected with a pulmonary sequestration.
Case report
A 35-year-old woman (gravida 4, para 0) achieved
pregnancy after IVF using frozen donor semen. At 8
weeks gestation a diagnosis of bichorial biamniotic twin
pregnancy was made. At 20 weeks ultrasound scan was
completely normal, and showed a first fetus that was fe-
male and a second one male, with normal development.
At 25 weeks of amenorrhea ultrasound scan revealed a
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second fetus (male) with mild hydramnios and a right
echogenic lung mass of 39×27 mm (Figure 1).
Colour flow Doppler and 3D sonography showed a
systemic artery arising from the thoracic aorta feeding
the mass (Figures 2, 3, 4).
Echocardiography was also performed and showed
unilateral right hydrothorax due to the presence of a lung
mass, and agenesis of right pulmonary veins. Heart and
vessels appeared as normal (Figure 5).
Figure 3. Feeding vessel arising from the thoracic aorta with power Dopp-
ler (pulse waved)
Slika 3. Opskrbna krvna `ila koja polazi iz torakalne aorte. Prikaz osna-
`enim doplerom
Figure 2. Feeding vessel arising from the thoracic aorta
Slika 2. Opskrbna krvna `ila iz torakalne aorte
Figure 1. Right echogenic lung mass and hydramnios
Slika 1. Desna ehogena plu}na masa i hidramnios
Figure 4. Feeding vessel arising from the thoracic aorta with 3D sono-
graphy
Slika 4. Opskrbna krvna `ila iz torakalne aorte prikazana 3D ultrazvukom
Figure 5. Fetal echocardiography: heart, unilateral right hydrothorax and
polyhydramnios
Slika 5. Fetalna ehokardiografija: srce, jednostrani desni hidrotoraks i
polihidramnion
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We also performed magnetic resonance imaging (MRI)
in an attempt to diagnose the aetiology of the lung mass,
in the event that this would provide further information.
However, the MRI only revealed a solid lung mass with
a feeding vessel, with no other associated pathology. We
thus considered pulmonary sequestration as the most
feasible diagnosis due to the presence of a solid chest
mass with a lobar shape and a feeding vessel arising
from the aorta.
Follow-up scans at 26 and 28 weeks revealed a first
fetus with oligohydramnios and a second fetus with in-
creased polyhydramnios, large unilateral hydrothorax of
65×45mm (Figure 6), mild ascites, mediastinal, cardiac
and diaphragmatic shift (Figure 7), and a right echo-
genic pulmonary mass of 45 mm.
The first fetus showed intrauterine growth retardation
at 30 weeks gestation. The patient was under tocolysis
treatment from 28 to 34 weeks. Ultrasonographic follow
up of cervix measurement changes showed this to be re-
duced during the pregnancy, thus threatening a prema-
ture labour. Fetal maturation with -methasone was ad-
ministered at 28 weeks.
Due to the increasing polyhydramnios and large hydro-
thorax, amniodrainage and thoracocenthesis were per-
formed at 29 weeks. This manoeuvre was repeated we-
ekly until 34 weeks gestation due to the increasing
Figure 7. Mediastinal, cardiac and diaphragmatic shift
Slika 7. Pomak mediastinuma, srca i o{ita
Figure 6. Large unilateral hydrothorax and solid lung mass
Slika 6. Veliki jednostrani hidrotoraks i solidna plu}na masa
Figure 8. Macroscopic view of the pulmonary sequestration after surgical
removal
Slika 8. Makroskopski izgled plu}ne sekvestracije nakon kirur{kog od-
stranjenja
Table 1. Amniodrainages and thoracocentheses. Fluid drained in each ma-
noeuvre





29 weeks 2,000 ml 100 ml
30 weeks 1,400 ml 50 ml
31.3 weeks 3,000 ml 90 ml
32.5 weeks 3,000 ml 90 ml
34 weeks 2,000 ml –
34.3 weeks 2.750 ml –
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hydramnios and hydrothorax over time. Table 1 shows
the amounts of amniotic and thoracic fluid drained in
each serial manoeuvre.
The patient went into spontaneous labour at 35 weeks
and a caesarean delivery was performed; this produced a
first fetus weighing 1980 g and a second fetus (affected)
weighing 2700 g. The affected fetus required ventilatory
support and surgery was performed at 26 days of life. The
pathologist confirmed the diagnosis of extralobar pulmo-
nary sequestration (Figure 8). Surgery was very success-
ful. The fetus showed no effects of pulmonary compres-
sion, and both neonates are now healthy at one-year fol-
low up.
Discussion
Routine application of ultrasonography enables a more
frequent antenatal diagnosis of congenital lung malfor-
mations, particularly pulmonary sequestration and cys-
tic adenomatoid malformation. Lung masses represent
an important and diverse group of fetal anomalies. The
two most common are congenital cystic adenomatoid
malformation (CCAM) and bronchopulmonary seques-
tration (BPS), which seem to be pathologically and clin-
ically distinct but frequently overlap.4
BPS involves a developmental mass of non-function-
ing bronchopulmonary tissue that is separated from the
tracheobronchial tree and receives arterial blood from
the systemic circulation. Pryce was the first to coin the
term »sequestration« (from Latin »sequestra«, meaning
to remove or separate) to describe this disconnected
bronchopulmonary mass or cyst with an anomalous sys-
temic arterial supply.10 Two subtypes were primarily de-
fined: the intralobar mass located within the substance
of the lung lobe, and the extralobar one, which has its
own pleural investment. The extralobar subtype can oc-
cur in the chest, including the pericardial sac, or in the
abdomen, whereas the intralobar subtype is limited to
the lung.4
Intralobar sequestrations account for 75–85% of all
sequestrations diagnosed in adults and are rarely detec-
ted in fetuses. In contrast, nearly all the sequestrations
diagnosed prenatally are extralobar. While they are re-
ported to account for 0.5 to 6% of all congenital lesions
of the thorax,11 extralobar sequestrations are known to
account for a greater proportion of lung masses detected
before birth. In one series, pulmonary sequestration ac-
counted for at least 12–16% of fetal chest masses mis-
diagnosed as CCAMs,12 and in another series published
by Adzick extralobar sequestration accounted for 23%
of the 175 fetal chest masses reported.8
According to Achiron et al,4 CCAM and BPS fre-
quently overlap and terms such as »hybrid form« and
»missing link« are confused, although they often appear
in the literature.13,14 These new conflicting data are the
tip of the iceberg of conjecture and controversy sur-
rounding the aetiology and pathogenesis of fetal lung le-
sions. Achiron et al.4 state that the classification of lung
anomalies according to traditional criteria has become
irrelevant. They review the latest pathological and pa-
thogenic aspects of CCAM and BPS in an attempt to
draw a parallel with prenatal ultrasound diagnosis, and
propose a new classification system based on the patho-
genesis of these malformations and their two-dimen-
sional and colour Doppler ultrasound characteristics.
They demonstrated the applicability of this new classifi-
cation in a clinical setting.15
Diagnosis
Extralobar pulmonary sequestrations are detected so-
nographically as well-circumscribed echogenic masses,
lobar or triangular in shape, and mostly in the base of the
left fetal chest. They tend to be small or moderately
sized lesions. Large sequestrations may occur and can
cause mediastinal shift and hydrops. The echotexture of
the mass is usually homogeneous, although cysts are oc-
casionally observed.
Visualization of a systemic artery arising from the
thoracic or abdominal aorta feeding the mass strongly
favours the diagnosis of extralobar pulmonary seques-
tration. The introduction of new technologies, such as
three-dimensional power Doppler ultrasound, has been
shown to be useful in identifying the feeding vessel and
thus establishing the diagnosis of pulmonary sequestra-
tion.16 In the case we report, colour flow Doppler and
three-dimensional power Doppler imaging showed a
systemic artery arising from the thoracic aorta feeding
the lung mass at 25 weeks of gestation. We believe that
demonstration of the vascular supply to the lesion is
probably the most important clue to the diagnosis of BPS.
A hydrothorax ipsilateral to the mass may occur in
5–10% of cases of extralobar pulmonary sequestration.
In a series published by Illanes,17 the median gestational
age at diagnosis was 21 weeks. In this series the associa-
tion with mediastinal shift, hydrothorax and hydrops
fetalis was the most predictive of prognostic factors.
The association with hydrops fetalis and poor outcome
in the presence of an echogenic lung is well-known.
There are several publications confirming high rates of
intrauterine or neonatal death with hydrops, even as
high as 100%.8,18 According to Illanes et al.,24 in spite of
the assessment of other prenatal markers, fetal hydrops
proved to be the single most useful predictor of fetal
death.
The likelihood of other anomalies is increased sligh-
tly in association with extralobar pulmonary sequestra-
tion. Some authors report an associated anomaly rate as
high as 50–65%.19,13 There are few reports associating
lung masses with aneuploidy.20,21 However, because of
the low incidence of chromosomal abnormalities, ka-
ryotyping is only recommended in cases with associated
abnormalities.24
Prognosis and Management
There is a wide spectrum of clinical severity for fe-
tuses with a lung mass such as pulmonary sequestration;
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this includes lesions that remain stable in size as the
pregnancy progresses, those that decrease or even dis-
appear3,7,22 and others associated with the development
of hydrops. However, spontaneous regression occurs
much less frequently for lesions with hydrops and there-
fore hydropic cases require fetal intervention. Indeed,
the association between hydrops fetalis and poor out-
come in the presence of pulmonary sequestration is well
established.
Pulmonary sequestrations may compromise the pre-
natal development of functioning parenchymal lung tis-
sue, and the resultant pulmonary hypoplasia at birth
leads to significant perinatal morbidity and mortality.
Hydrops fetalis may develop and the association with
polyhydramnios may also increase the risk of prema-
turity, furthering the risk of perinatal loss. As pulmonary
sequestration can now be readily diagnosed the question
arises as to whether any in utero intervention can im-
prove prognosis.30 We have found that the overall prog-
nosis depends on the size of the lung mass and second-
ary pathophysiological effects. If the pleural effusion is
small and no mediastinal shift is demonstrated interven-
tion might not be justified; on the other hand, if signifi-
cant mediastinal shift or hydrops develop, intervention
is warranted.8,23,24
The main treatment consists in decompressing the fe-
tal hydrothorax by in utero thoracoamniotic shunting or
repeated thoracocentesis, which have been reported to
improve the prognosis.9,25–29 There are also reports of
successful expectant management in hydropic fetuses
with lung sequestration. Other therapeutic options in-
clude medical inotropic therapy,30 alcohol ablation or
laser ablation of the vascular pedicle. These various
strategies of in utero management have been designed to
relieve mediastinal compression, thus allowing subse-
quent ex utero surgical treatment.
Open fetal surgery and immediate delivery is not well
considered due to the high risk of neonatal death in
hydropic infants, in whom resuscitation manoeuvres are
particularly difficult.31
In 2006, Know et al.30 published a review about in
utero management of primary hydrothorax and congeni-
tal cystic lung lesions complicated with pleural effusion.
They selected the most relevant papers about the effect
of prenatal pulmonary drainage (shunt, drainage or sur-
gery) on perinatal survival and compared them with pa-
pers that reported cases with lung pathology that under-
went no treatment. They concluded that in fetuses af-
fected with hydrops fetalis, in utero drainage improved
their perinatal survival. However, the authors highlight
the absence of randomized studies and long-term fol-
low-up. Otherwise, there is no agreement as to the tim-
ing and exact clinical presentation which would benefit
from in utero treatment.
The present case is interesting because of the coexis-
tence of a normal fetus and an affected fetus with a lung
abnormality, the latter with poor prognosis due to the
presence of increasing and enlarged hydrothorax and
polyhydramnios. We have only found two papers in
the literature reporting cases of twin pregnancies in
which one fetus was affected with increasing pleural ef-
fusion.32,33 In both cases one fetus was affected by pri-
mary pleural effusions and treated with thoracoamniotic
shunting. The shunt was inserted successfully before
twenty weeks gestation, subsequent to which the lungs
re-expanded and the hydrops resolved.
We have not found any reports of twin pregnancy in
which one fetus was affected with a lung mass compli-
cated with hydrothorax and polyhydramnios, as in our
case. Fetal therapy such as shunting was the best choice
to treat the affected fetus, but in our case the pregnancy
was threatened by preterm labour at the moment the
hydrops and polyhydramnios were diagnosed. Because
of this, thoracoamniotic shunting was not considered as
a possibility. A preterm delivery could have compli-
cated the outcome of both fetuses, the one affected with
pulmonary sequestration and the other healthy one; in-
deed, the main morbidity associated with fetal surgery is
preterm delivery (71% incidence has been reported).35
The increasing hydrothorax and polyhydramnios meant
that spontaneous regression of the symptoms was highly
unlikely, and thus conservative management (no treat-
ment) was also ruled out.
Given the above, and after consulting with fetal sur-
gery specialists, we decided to perform amniodrainage
and single needle pleural fluid aspirations. Thoraco-
centesis alone often results in rapid reaccumulation of
fluid, because the underlying pathophysiological cause
of the effusion has not been corrected. We thus had to
perform serial amniodrainage and thoracocentesis to
avoid the accumulation of fluid and prevent fetal lung
hypoplasia.
Conclusion
We believe that each case should be evaluated in an
individual and integral way. The survival rate in cases of
pulmonary sequestrations may be improved with the ap-
propriate investigation and therapy. The decisive crite-
ria are the underlying defect as well as the severity and
progression of the hydrothorax. The choice of which
therapy should be performed remains controversial, al-
though thoracoamniotic shunting appears as the first
strategy.34 Twin pregnancies make the decision more
difficult because of the presence of a healthy and an af-
fected fetus.
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